These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 24759557

  • 1. Factors contributing to an accelerated decline in pulmonary function in asthma.
    Kanemitsu Y, Matsumoto H, Mishima M, KiHAC Respiratory Medicine Group.
    Allergol Int; 2014 Jun; 63(2):181-8. PubMed ID: 24759557
    [Abstract] [Full Text] [Related]

  • 2. Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids.
    Kanemitsu Y, Matsumoto H, Izuhara K, Tohda Y, Kita H, Horiguchi T, Kuwabara K, Tomii K, Otsuka K, Fujimura M, Ohkura N, Tomita K, Yokoyama A, Ohnishi H, Nakano Y, Oguma T, Hozawa S, Nagasaki T, Ito I, Oguma T, Inoue H, Tajiri T, Iwata T, Izuhara Y, Ono J, Ohta S, Tamari M, Hirota T, Yokoyama T, Niimi A, Mishima M.
    J Allergy Clin Immunol; 2013 Aug; 132(2):305-12.e3. PubMed ID: 23791506
    [Abstract] [Full Text] [Related]

  • 3. Serum periostin: a novel biomarker for asthma management.
    Matsumoto H.
    Allergol Int; 2014 Jun; 63(2):153-60. PubMed ID: 24759559
    [Abstract] [Full Text] [Related]

  • 4. GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids.
    Izuhara Y, Matsumoto H, Kanemitsu Y, Izuhara K, Tohda Y, Horiguchi T, Kita H, Kuwabara K, Tomii K, Otsuka K, Fujimura M, Ohkura N, Tomita K, Yokoyama A, Ohnishi H, Nakano Y, Oguma T, Hozawa S, Nagasaki T, Ito I, Oguma T, Inoue H, Tajiri T, Iwata T, Ono J, Ohta S, Tamari M, Hirota T, Yokoyama T, Niimi A, Mishima M.
    Allergy; 2014 May; 69(5):668-73. PubMed ID: 24673601
    [Abstract] [Full Text] [Related]

  • 5. Serum periostin levels serve as a biomarker for both eosinophilic airway inflammation and fixed airflow limitation in well-controlled asthmatics.
    Takahashi K, Meguro K, Kawashima H, Kashiwakuma D, Kagami SI, Ohta S, Ono J, Izuhara K, Iwamoto I.
    J Asthma; 2019 Mar; 56(3):236-243. PubMed ID: 29648484
    [Abstract] [Full Text] [Related]

  • 6. Roles of Periostin in Asthma.
    Matsumoto H.
    Adv Exp Med Biol; 2019 Mar; 1132():145-159. PubMed ID: 31037633
    [Abstract] [Full Text] [Related]

  • 7. Effect of treatment with inhaled corticosteroid on serum periostin levels in asthma.
    Hoshino M, Ohtawa J, Akitsu K.
    Respirology; 2016 Feb; 21(2):297-303. PubMed ID: 26607392
    [Abstract] [Full Text] [Related]

  • 8. Effect of inhaled corticosteroids on serum periostin levels in adult patients with mild-moderate asthma.
    Solanki B, Prakash A, Rehan HS, Gupta LK.
    Allergy Asthma Proc; 2019 Jan 01; 40(1):32-34. PubMed ID: 30582493
    [Abstract] [Full Text] [Related]

  • 9. Inhaled corticosteroids in children: use and effects of early treatment on asthma and lung function. Prevalence of asthma and the impact of severity in early life on later asthma in childhood.
    Devulapalli CS.
    Clin Respir J; 2008 Oct 01; 2(4):247-8. PubMed ID: 20298343
    [Abstract] [Full Text] [Related]

  • 10. Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.
    Paro-Heitor ML, Bussamra MH, Saraiva-Romanholo BM, Martins MA, Okay TS, Rodrigues JC.
    Pediatr Pulmonol; 2008 Feb 01; 43(2):134-41. PubMed ID: 18085692
    [Abstract] [Full Text] [Related]

  • 11. Inhaled corticosteroids and decline of lung function in community residents with asthma.
    Lange P, Scharling H, Ulrik CS, Vestbo J.
    Thorax; 2006 Feb 01; 61(2):100-4. PubMed ID: 16443705
    [Abstract] [Full Text] [Related]

  • 12. Asthmatics able to step down from inhaled corticosteroid treatment without loss of asthma control have low serum eotaxin/CCL11.
    Hoffmann HJ, Nielsen LP, Harving H, Heinig JH, Dahl R.
    Clin Respir J; 2008 Jul 01; 2(3):149-57. PubMed ID: 20298323
    [Abstract] [Full Text] [Related]

  • 13. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex.
    Dijkstra A, Vonk JM, Jongepier H, Koppelman GH, Schouten JP, ten Hacken NH, Timens W, Postma DS.
    Thorax; 2006 Feb 01; 61(2):105-10. PubMed ID: 16308336
    [Abstract] [Full Text] [Related]

  • 14. Role of serum periostin in the management of asthma and its comorbidities.
    Matsumoto H.
    Respir Investig; 2020 May 01; 58(3):144-154. PubMed ID: 32205146
    [Abstract] [Full Text] [Related]

  • 15. Severe exacerbations predict excess lung function decline in asthma.
    Bai TR, Vonk JM, Postma DS, Boezen HM.
    Eur Respir J; 2007 Sep 01; 30(3):452-6. PubMed ID: 17537763
    [Abstract] [Full Text] [Related]

  • 16. Association of airway wall thickness with serum periostin in steroid-naive asthma.
    Hoshino M, Ohtawa J, Akitsu K.
    Allergy Asthma Proc; 2016 May 01; 37(3):225-30. PubMed ID: 27178891
    [Abstract] [Full Text] [Related]

  • 17. [Association between body mass index and lung function in children with asthma after corticosteroids inhalation].
    Ye ZH, Huang Y, Wang Y, Wang DJ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Nov 01; 15(11):983-6. PubMed ID: 24229594
    [Abstract] [Full Text] [Related]

  • 18. Serum periostin in obstructive airways disease.
    Fingleton J, Braithwaite I, Travers J, Bowles D, Strik R, Siebers R, Holweg C, Matthews J, Weatherall M, Beasley R, NZRHS Study Group.
    Eur Respir J; 2016 May 01; 47(5):1383-91. PubMed ID: 26917610
    [Abstract] [Full Text] [Related]

  • 19. Association of serum periostin with aspirin-exacerbated respiratory disease.
    Kim MA, Izuhara K, Ohta S, Ono J, Yoon MK, Ban GY, Yoo HS, Shin YS, Ye YM, Nahm DH, Park HS.
    Ann Allergy Asthma Immunol; 2014 Sep 01; 113(3):314-20. PubMed ID: 25037608
    [Abstract] [Full Text] [Related]

  • 20. Periostin, a novel biomarker of TH2-driven asthma.
    Parulekar AD, Atik MA, Hanania NA.
    Curr Opin Pulm Med; 2014 Jan 01; 20(1):60-5. PubMed ID: 24247042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.